Clinical Trial Update: Usefulness of DORNASE in COVID-19 on HFNO [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the usefulness of DORNASE in COVID-19 pneumonia on high-flow nasal oxygen; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: COVID-19 Pneumonia | Phase 4 | Status: TERMINATED